Petros Pharmaceuticals, Inc.
PTPI
$0.0199
-$0.038-65.63%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -317.59% | -235.45% | 69.39% | -779.67% | 106.99% |
| Total Depreciation and Amortization | -13.15% | 1.80% | 0.16% | -10.00% | -2.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5,233.82% | 90.31% | 0.38% | 71.26% | -459.62% |
| Change in Net Operating Assets | 169.93% | 395.66% | -115.88% | 0.85% | 197.24% |
| Cash from Operations | 225.18% | 53.61% | -46.49% | 49.79% | 44.15% |
| Capital Expenditure | 71.73% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 71.73% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -1.50% | -- | -- | -1.52% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 52.09% | -51.38% | -40.76% | 43.90% | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 58.75% | -41.70% | -74.63% | 52.75% | -116.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.82% | 1.53% | -60.47% | 51.30% | -143.77% |